「cardiovascular」の共起表現一覧(1語右で並び替え)
該当件数 : 329件
| mice without the endoglin gene die due to | cardiovascular abnormalities. |
| g Tetrahydropalmatine also has a number of | cardiovascular actions. |
| ood circulation, as in many other forms of | cardiovascular activity. |
| did the authors report that the cutoff for | cardiovascular adverse events was before that for gastroi |
| Cardiovascular agents, coagulation/fibrinolytic agents, i | |
| hirsutism and hypertriglyceridemia. Common | cardiovascular alterations related to this syndrome are c |
| 0, employs 300 people in the production of | cardiovascular and anti-fungal medicines. |
| More recently, the | cardiovascular and neuronal importance of nitric oxide ha |
| es an FDA-mandated "black box warning" for | cardiovascular and gastrointestinal risk. |
| Among its specialties are its Cardiology, | Cardiovascular and Thoracic Surgery Departments, and its |
| ng research and education in the fields of | cardiovascular and interventional radiology. |
| ishes a bimonthly medical journal entitled | CardioVascular and Interventional Radiology as well as ot |
| Nervous system, | cardiovascular and musculoskeletal examinations are unrem |
| ditional Chinese medicine for treatment of | cardiovascular and cerebrovascular diseases and to preven |
| y 7, 2007, New York City) was a pioneering | cardiovascular and thoracic surgeon. |
| e Transatlantic Networks of Excellence for | Cardiovascular and Neurovascular Research, is unique in t |
| work together to advance the knowledge in | cardiovascular and neurovascular disease. |
| Manuel Chavez (born 25 December 1931) is a | cardiovascular and thoracic surgeon best known for his pa |
| causes depression as a side effect of the | cardiovascular and anti-psychotic effects. |
| Cardiovascular and metabolic diseases | |
| On December 11, 2007, the | Cardiovascular and Renal Drugs Advisory Committee of the |
| on of whether CLA may increase the risk of | cardiovascular and inflammatory diseases, but it has yet |
| tific discoveries into clinical benefit in | cardiovascular and neurovascular disease through targeted |
| ution) can be used, because they have less | cardiovascular and central nervous system toxicity than r |
| It can result in | cardiovascular and brain damage, specifically in the cent |
| n to food intake, from memory processes to | cardiovascular and renal functions, from spontaneous loco |
| utes generic pharmaceuticals primarily for | cardiovascular and central nervous system aliments. |
| 1966-1967), teaching and doing research in | cardiovascular and exercise physiology. |
| percholesterolemia, diabetes mellitus, and | cardiovascular and cerebrovascular disease. |
| at there may be potential benefits against | cardiovascular and inflammatory diseases, vision-related |
| s to rise, which has been shown to produce | cardiovascular and skeletal problems. |
| intments, Dr Gotto chairs the Committee on | Cardiovascular and Metabolic Diseases (CCMD), a multiface |
| ome of the age-related diseases, including | cardiovascular and neurodegenerative disorders, have been |
| The | Cardiovascular and Interventional Radiological Society of |
| ected recommending boxed warnings for both | cardiovascular and psychiatric adverse effects. |
| it a wide range of bioactivities including | cardiovascular, antihepatotoxic, choleretic, hypoglycemic |
| thopedics, plastic surgery, drug delivery, | cardiovascular applications, and tissue engineering. |
| including a 75-foot (23 m) lap pool; large | cardiovascular area with exercise equipment; locker rooms |
| ted to heart disease (hypertension related | cardiovascular), cancer, stroke (cerebrovascular diseases |
| g research, development and consultancy in | cardiovascular care issues, particularly emergency and cr |
| of specialties to include women's health, | cardiovascular care and orthopedic, stroke, and rehabilit |
| ; cancer services; intensive, coronary and | cardiovascular care units; endoscopy; surgical services; |
| sole, independent provider of specialized | cardiovascular care for the Champlain Local Health Integr |
| acute care facility, offering services in | cardiovascular care, spine treatment, women's health, maj |
| It specializes in | cardiovascular care. |
| He now has a | Cardiovascular Center in Brookline, MA called Lown Cardio |
| er at Mercy Hospital is one of the premier | cardiovascular centers in South Florida, ranking among th |
| The | cardiovascular collapse theory is a prevalent modern expl |
| nd strenuous physical exertion, leading to | cardiovascular collapse. |
| Saint Thomas Heart to its list of top 100 | cardiovascular community hospitals. |
| While alfentanil tends to cause less | cardiovascular complications than other similar drugs suc |
| ht management program reduces the risk for | cardiovascular complications in people at high risk for h |
| ecreasing heart attacks, strokes and other | cardiovascular complications. |
| on, trainees underwent weight training and | cardiovascular conditioning exercises. |
| e risks of stroke, heart attack, and other | cardiovascular conditions. |
| ver the age of 35, and certain preexisting | cardiovascular conditions. |
| ines and so could be used in patients with | cardiovascular conditions. |
| luding kidney damage, neurological damage, | cardiovascular damage, damage to the retina etc. |
| als: for example, it is possible to record | cardiovascular data at the same time as respiratory data |
| italization for worsening heart failure or | cardiovascular death by 18% (P<0.0001) |
| tty acids reduced the occurrence of death, | cardiovascular death, and sudden cardiac death by 20%, 30 |
| showed a dose-related increase in risk of | cardiovascular death, myocardial infarction, stroke, or h |
| ncreased risk of heart attacks, stroke and | cardiovascular death. |
| People who are hyperactive or have | cardiovascular difficulties should not use this product b |
| supplement provided any protection against | cardiovascular disease in the HOPE study. |
| O'Malley died from | cardiovascular disease in San Juan Capistrano in Orange C |
| He died from | cardiovascular disease at the age of 50 in McLean, Virgin |
| role of homocysteine as a risk factor for | cardiovascular disease is suggested to be mediated by hom |
| of the Leadership Council on the Kidney in | Cardiovascular Disease of the American Heart Association. |
| adult and childhood cancer, ALS, diabetes, | cardiovascular disease and hearing loss. |
| ar and renal damage caused by diabetes and | cardiovascular disease (CVD). |
| Payne died at his home in Natchitoches of | cardiovascular disease and the lingering effects of influ |
| of the National Institutes of Health (NIH) | Cardiovascular Disease Advisory Committee, and he served |
| ation from 1931 to 1932, when he died from | cardiovascular disease at the age of sixty-eight. |
| ly development of faith-based programs for | cardiovascular disease prevention. |
| ies with oral contraceptives, the risk for | cardiovascular disease (such as thromboembolism) is signi |
| he joined at age 13, until his death from | cardiovascular disease on June 24, 2008. |
| has focused on understanding and treating | cardiovascular disease at the molecular level and the stu |
| 's double-decker buses had higher rates of | cardiovascular disease than the conductors who climbed th |
| ascular relaxation observed in humans with | cardiovascular disease or risk factors (such as hyperchol |
| A review of ayurveda and | cardiovascular disease concluded that while the herbal ev |
| ons, but he was troubled by heart disease, | cardiovascular disease and ulcers, and developed a reputa |
| se relationship between water hardness and | cardiovascular disease in men, up to a level of 170 mg ca |
| Following his death from | cardiovascular disease on September 24, 1939, in Beverly |
| gnificant conditions, such as hypertensive | cardiovascular disease and pulmonary emphysema," Supervis |
| en had one of the highest death rates from | cardiovascular disease in the nation. |
| Deacon died from | cardiovascular disease in 1984. |
| Cardiovascular disease (post heart attack recovery, circu | |
| ol in the blood) and for the prevention of | cardiovascular disease outside South and Southeast Asia a |
| and Principal Investigator) for preventing | cardiovascular disease 1972-1977, during which time, card |
| e mortality and a 26 percent lower risk of | cardiovascular disease ("CVD") than participants who cons |
| He died at his Baton Rouge home of | cardiovascular disease at the age of seventy-six. |
| erhaps the first person to analyze data on | cardiovascular disease and activity. |
| tients on Cardura had a 25% higher rate of | cardiovascular disease and twice the rate of congestive h |
| to the 1990s, and died of arteriosclerotic | cardiovascular disease in 2004. |
| l of the affected patients had preexisting | cardiovascular disease or risk factors for such, and furt |
| oring in patients with severe pre-existing | cardiovascular disease who are taking SSRI's. |
| He suffered from | cardiovascular disease and had several major strokes that |
| Elevated homocysteine is a risk factor for | cardiovascular disease and is linked to the metabolic syn |
| has also been linked to increased risk of | cardiovascular disease including heart attack. |
| Bell died from | cardiovascular disease in Tasmania, and was buried in the |
| se in amyloidosis, Alzheimer's disease and | cardiovascular disease". |
| jor roles in influencing susceptibility to | cardiovascular disease, diabetes, and obesity. |
| enter at San Antonio focuses on nutrition, | cardiovascular disease, health education, and early child |
| utrition is linked to an increased risk of | cardiovascular disease, obesity, type II diabetes and hyp |
| range of therapeutic areas including CNS, | cardiovascular disease, inflammation and cancer. |
| ith advanced arteriosclerosis, symptomatic | cardiovascular disease, moderate to severe hypertension, |
| odified lipoproteins in the progression of | cardiovascular disease, seeking ways to convert research |
| n increased risk of developing alcoholism, | cardiovascular disease, malabsorption, chronic pancreatit |
| with adverse human health consequences for | cardiovascular disease, metabolic diseases and also a wid |
| ng is required for those with a history of | cardiovascular disease, stroke, glaucoma, and/or seizures |
| as suicide but also natural causes such as | cardiovascular disease, to which smoking is an important |
| World map of | cardiovascular disease, 2004. |
| tories in 1935, Cipla makes drugs to treat | cardiovascular disease, arthritis, diabetes, weight contr |
| He is board certified in | cardiovascular disease, clinical cardiac electrophysiolog |
| siological processes including hemostasis, | cardiovascular disease, and stroke. |
| ve been implicated in Alzheimer's Disease, | cardiovascular disease, and stroke. |
| Huchard specialized in the study of | cardiovascular disease, and is remembered for his researc |
| ology, family medicine, internal medicine, | cardiovascular disease, endocrinology, gastroenterology, |
| tan sulfate may have roles in coagulation, | cardiovascular disease, carcinogenesis, infection, wound |
| on of inflammatory factors associated with | cardiovascular disease. |
| ted cholesterol) and for the prevention of | cardiovascular disease. |
| ements will provide any protection against | cardiovascular disease. |
| s such as cancer, infectious diseases, and | cardiovascular disease. |
| in turn is a risk factor for some types of | cardiovascular disease. |
| l levels, and serum cholesterol levels and | cardiovascular disease. |
| and may be involved in kidney failure and | cardiovascular disease. |
| treat hypercholesterolemia and to prevent | cardiovascular disease. |
| ), clouding of the cornea, and early-onset | cardiovascular disease. |
| rol and related conditions, and to prevent | cardiovascular disease. |
| 9 on November 8, 2010, due to hypertensive | cardiovascular disease. |
| prevention of Type 2 Diabetes Mellitus and | cardiovascular disease. |
| ed for lowering cholesterol and preventing | cardiovascular disease. |
| esterol levels, and the mass occurrence of | cardiovascular disease. |
| the prevention, diagnosis and treatment of | cardiovascular disease. |
| he ACE inhibitors used in the treatment of | cardiovascular disease. |
| ated with dramatic increase in the risk of | cardiovascular disease. |
| bile acid production or increased risk for | cardiovascular disease. |
| ams regarding diabetes, cancer, lupus, and | cardiovascular disease. |
| cardial infarction and/or death related to | cardiovascular disease. |
| s with diabetes, chronic renal failure, or | cardiovascular disease. |
| her platform focuses on the prevention of | cardiovascular disease. |
| ocystinemia" is a powerful risk factor for | cardiovascular disease. |
| cholesterol levels in patients at risk of | cardiovascular disease. |
| ch as diabetes, hypertension, arthritis or | cardiovascular disease. |
| e treatment of various forms of cancer and | cardiovascular disease. |
| hondrial dysfunction, such as diabetes and | cardiovascular disease., |
| ial risks and consequences: psychological; | cardiovascular disease; among additional risks including |
| s from oxidative damage and reduce risk of | cardiovascular diseases and cancer. |
| The National Institute of | Cardiovascular Diseases (NICVD), was established in 1963 |
| 3. Hypertension and | cardiovascular diseases The activities in this area focus |
| Cardiovascular diseases | |
| edical research in the fields of renal and | cardiovascular diseases and, later, oncology at the Karol |
| National Institute of | Cardiovascular Diseases (NICVD), Dhaka, Bangladesh (1963) |
| n drugs used in non-communicable diseases ( | cardiovascular diseases and hypertension in particular). |
| th pre-existing blood pressure problems or | cardiovascular diseases should always make sure that thei |
| cellor of the Health Sciences Division for | Cardiovascular Diseases and is in charge of the developme |
| nd Health Disparities Research, Center for | Cardiovascular Diseases, Center for Human Performance and |
| ation of blood pressure, blood flow and in | cardiovascular diseases, tetrahydrobiopterin is a potenti |
| metabolic disorders, monogenetic diseases, | cardiovascular diseases, analgesia…. |
| in the initiation of retinal dysfunction, | cardiovascular diseases, type II diabetes, and many other |
| cal distribution of mortality from cancer, | cardiovascular diseases, perinatal and other selected con |
| lly reduce the risk of certain cancers and | cardiovascular diseases. |
| k along with allowing them to better treat | cardiovascular diseases. |
| ard oil may afford some protection against | cardiovascular diseases. |
| Potential use of Lq2 is mainly in | cardiovascular diseases. |
| st platform for the treatment of blood and | cardiovascular diseases. |
| t is PPHG, not FPG, which is the marker of | cardiovascular disorders associated with diabetes. |
| le (lower jaw bone), cleft lip and palate, | cardiovascular disorders, diaphragmatic hernia, and gastr |
| Pregnancy, lactation; severe | CardioVascular disorders; asthma; angle-closure glaucoma, |
| d salts may cause reproductive defects and | cardiovascular disturbances. |
| e creation of 'Viagra' as well as numerous | cardiovascular drugs |
| ed in diabetes and/or hypertension-induced | cardiovascular dysfunction; b)understanding the biologica |
| result in central nervous system (CNS) and | cardiovascular effects - CNS effects usually occur at low |
| Cardiovascular effects include hypotension, bradycardia, | |
| e emerging hypothesis that may explain the | cardiovascular effects is that coxibs create an imbalance |
| he failure to categorically state that the | cardiovascular effects following histamine release were t |
| ansient effects: the total duration of the | cardiovascular effects is no more than one to two minutes |
| he evidence is not conclusive, the adverse | cardiovascular effects of smokeless tobacco use are less |
| ypothesize that positive emotions undo the | cardiovascular effects of negative emotions. |
| stimulant with epileptogenic activity and | cardiovascular effects such a hypotension and bradycardia |
| Ephedrine's | cardiovascular effects have previously been shown to be p |
| oxidation of LDL cholesterol and resultant | cardiovascular effects. |
| paya leaves which has been studied for its | cardiovascular effects. |
| Ephedrine's | cardiovascular effects[18] have previously been shown to |
| Journal of | Cardiovascular Electrophysiology, 14, 1-5. |
| California, United States, specializing in | cardiovascular emergencies. |
| g orthostatic hypotension of neurological, | cardiovascular, endocrine or metabolic origin. |
| has done research on cancer, perinatal and | cardiovascular epidemiology. |
| A 5,600 square feet (520 m2) room with | cardiovascular equipment |
| t Soriano near Viterbo, where he died of a | cardiovascular event (the sources differ on whether it wa |
| showed in a study increase in incidence of | cardiovascular events when taking parecoxib and valdecoxi |
| rance database, no increase in the risk of | cardiovascular events were found under tegaserod treatmen |
| ily did not experience significantly fewer | cardiovascular events or hospitalizations for heart failu |
| over 18,000 patients demonstrated adverse | cardiovascular events in 13 of 11,614 patients treated wi |
| PERFORM (Prevention of cerebrovascular and | cardiovascular Events of ischemic origin with teRutroban |
| he same study, no reduction in the rate of | cardiovascular events (including death) was shown. |
| rly because patients showed no decrease in | cardiovascular events, but did experience an increase in |
| lower the rate of recurrent stroke, major | cardiovascular events, or diabetes. |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると
|
検索履歴を保存できる！
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
